Granulomatosis with polyangiitis
RareAutoimmune
Granulomatosis with polyangiitis is treated with 1 medication in our database, including TAVNEOS. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Amgen. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Granulomatosis with polyangiitis treatment below.
What help exists for Granulomatosis with polyangiitis
3
drugs indexed
2
with copay cards
2
with patient assistance
3
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Granulomatosis with polyangiitis
3 total🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Granulomatosis with polyangiitis drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | Yes | — | — |
Grants for Granulomatosis with polyangiitis patients
8 total · 3 open- open
Amgen Assist 360
Amgen
Covers: financial assistance
- open
TAVNEOS Support
Amgen
Covers: financial assistance
- open
Amgen SupportPlus Patient Support Program
Amgen
- unknown
Amgen Support Plus
Amgen
- unknown
Amgen Assist 360
Amgen
Covers: financial assistance
- unknown
Amgen Support Plus
Amgen
- unknown
AMGEN Assist
Amgen
Covers: financial assistance
- unknown
Amgen Patient Assistance Program
Amgen
Covers: financial assistance
Granulomatosis with polyangiitis is a rare disease — more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare →